Aurora Kinase B‐Instruct Release of AZD1152‐HQPA from Hydrogel to Enhance Cervical Cancer Suppression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora Kinase B‐Instruct Release of AZD1152‐HQPA from Hydrogel to Enhance Cervical Cancer Suppression
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-06
DOI
10.1002/adfm.202309984
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional Supramolecular Filament Hydrogel Boosts Anti‐Inflammatory Efficacy In Vitro and In Vivo
- (2022) Jie Deng et al. ADVANCED FUNCTIONAL MATERIALS
- Clinical translation of long-acting drug delivery formulations
- (2022) Wei Li et al. Nature Reviews Materials
- Salt‐Inducible Kinase 2‐Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis
- (2022) Yue Hua et al. Advanced Science
- Trident Molecule with Nanobrush–Nanoparticle–Nanofiber Transition Property Spatially Suppresses Tumor Metastasis
- (2022) Ge Gao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Translational Applications of Hydrogels
- (2021) Santiago Correa et al. CHEMICAL REVIEWS
- Soft Materials by Design: Unconventional Polymer Networks Give Extreme Properties
- (2021) Xuanhe Zhao et al. CHEMICAL REVIEWS
- Cervical Cancer Immunotherapy: Facts and Hopes
- (2021) Louise Ferrall et al. CLINICAL CANCER RESEARCH
- Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer
- (2021) Naheed Arfin Borah et al. MOLECULES
- Vaginal drug delivery approaches for localized management of cervical cancer
- (2021) Xue Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Selective Degradation of PD‐L1 in Cancer Cells by Enzyme‐Instructed Self‐Assembly
- (2021) Yuhan Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Bioinspired Intrinsic Versatile Hydrogel Fabricated by Amyloidal Toxin Simulant‐Based Nanofibrous Assemblies for Accelerated Diabetic Wound Healing
- (2021) Qize Xuan et al. ADVANCED FUNCTIONAL MATERIALS
- Structurally Dynamic Hydrogels for Biomedical Applications: Pursuing a Fine Balance between Macroscopic Stability and Microscopic Dynamics
- (2021) Kunyu Zhang et al. CHEMICAL REVIEWS
- Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
- (2021) Nicoletta Colombo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
- (2020) Feihu Wang et al. Science Advances
- Intracellular Self‐Assembly of Peptide Conjugates for Tumor Imaging and Therapy
- (2020) Yu Deng et al. Advanced Healthcare Materials
- Receptor tyrosine kinases-instructed release of its inhibitor from hydrogel to delay ovarian aging
- (2020) Zhonghua Shi et al. BIOMATERIALS
- Cervical cancer
- (2019) Paul A Cohen et al. LANCET
- Viral-Mediated AURKB Cleavage Promotes Cell Segregation and Tumorigenesis
- (2019) Qing Zhu et al. Cell Reports
- AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
- (2019) Jordi Bertran-Alamillo et al. Nature Communications
- Systemic therapy for cervical carcinoma – current status
- (2018) Krystyna Serkies et al. Chinese Journal of Cancer Research
- Immune Responsive Release of Tacrolimus to Overcome Organ Transplant Rejection
- (2018) Jindao Wu et al. ADVANCED MATERIALS
- Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
- (2017) Krishnansu S Tewari et al. LANCET
- Injectable hydrogel-based drug delivery systems for local cancer therapy
- (2016) Mohammad Norouzi et al. DRUG DISCOVERY TODAY
- Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases
- (2016) P. Sini et al. MOLECULAR CANCER THERAPEUTICS
- Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
- (2015) Xuewen Du et al. CHEMICAL REVIEWS
- Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
- (2015) Ryo Kitagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy
- (2015) András Micsonai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
- (2015) Christian O. de Groot et al. Frontiers in Oncology
- The aurora kinases in cell cycle and leukemia
- (2014) B Goldenson et al. ONCOGENE
- Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia
- (2013) Hagop M. Kantarjian et al. CANCER
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia
- (2011) B. Lowenberg et al. BLOOD
- Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
- (2010) A. A. Dar et al. MOLECULAR CANCER THERAPEUTICS
- GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models
- (2009) M. A. Hardwicke et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started